(Q44655061)

5 December 2017

Short-course therapy with imiquimod 5% cream for solar keratoses: a randomized controlled trial (English)

1 reference

5 December 2017

Short‐course therapy with imiquimod 5% cream for solar keratoses: A randomized controlled trial (English)

1 reference

https://api.crossref.org/works/10.1046/J.1440-0960.2003.00003.X

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1440-0960.2003.00003.X

1 April 2024

author name string

Keng Chen

1

1 reference

5 December 2017

Lee Mei Yap

2

1 reference

5 December 2017

Robin Marks

3

1 reference

5 December 2017

Stephen Shumack

4

1 reference

5 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14616490

1 April 2024

publication date

1 November 2003

1 reference

full work available at URL

5 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1440-0960.2003.00003.x

1 reference

https://api.crossref.org/works/10.1046/J.1440-0960.2003.00003.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1440-0960.2003.00003.x

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1440-0960.2003.00003.X

Australasian Journal of Dermatology

1 April 2024

published in

1 reference

5 December 2017

44

1 reference

5 December 2017

4

1 reference

5 December 2017

250-255

1 reference

Immunomodulatory and pharmacologic properties of imiquimod

5 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-0960.2003.00003.X

Imiquimod 5% cream in the treatment of Bowen's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-0960.2003.00003.X

Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-0960.2003.00003.X

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-0960.2003.00003.X

Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-0960.2003.00003.X

Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-0960.2003.00003.X

Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-0960.2003.00003.X

Reduction of solar keratoses by regular sunscreen use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-0960.2003.00003.X

21 January 2018

Identifiers

1 reference

5 December 2017

1 reference